Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filedlitigationCriticalhttps://patents.darts-ip.com/?family=61147231&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2017000601(A1)"Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bristol Myers Squibb CofiledCriticalBristol Myers Squibb Co
Priority to CL2017000601ApriorityCriticalpatent/CL2017000601A1/en
Publication of CL2017000601A1publicationCriticalpatent/CL2017000601A1/en
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Abstract
<p>LA PRESENTE DESCRIPCIÓN PROPORCIONA PÉPTIDOS MACROCÍCLICOS NOVEDOSOS QUE INHIBEN LAS INTERACCIONES PROTEÍNA/PROTEÍNA PPD-1/PD-L1 Y PD-L1/CD80, Y POR ENDE, SON ÚTILES PARA LA MEJORA DE VARIAS ENFERMEDADES, QUE INCLUYEN EL CÁNCER Y LAS ENFERMEDADES INFECCIOSAS.</p><p> THIS DESCRIPTION PROVIDES NOVELTY MACROCYCLIC PEPTIDES THAT INHIBIT THE PROTEIN / PROTEIN INTERACTIONS PPD-1 / PD-L1 AND PD-L1 / CD80, AND THEREFORE, ARE USEFUL FOR THE IMPROVEMENT OF VARIOUS DISEASES, WHICH INCLUDE AND C INFECTIOUS DISEASES. </p>
CL2017000601A2017-03-102017-03-10
Macrocyclic inhibitors of protein / protein programmed death interactions 1 (pd-1) / pd-l1 and cd80 (b7-1) / pd-l1
CL2017000601A1
(en)
methods of disrupting odor perception behavior in an organism with an orc ion channel and agonizing an orc ion channel, composition for disrupting odor perception, and, article.
MACROCYCLIC INHIBITORS OF THE INTERACTIONS: PROTEIN OF THE SCHEDULED DEATH (PD-1) WITH ITS BIDDING (PD-L1) [INTERACTION PD-1 / PD-L1] AND OF THE DIFFERENTIATION Cumulus 80 (CD80) ALSO KNOWN AS PROTEIN B7-1 WITH LINK 1 OF THE PROGRAMMED DEATH PROTEIN (PD-L1) [CD80 OR B7-1 / PD-L1 INTERACTION]